FOXC1 Inhibitors
The transcription factor FOXC1 holds a pivotal position in orchestrating various cellular processes, and a diverse array of chemical inhibitors has been identified to finely modulate its activity. Direct inhibition is exemplified by compounds like ML-18 and FDI-6, which specifically target FOXC1, disrupting its transcriptional activity and inducing alterations in the expression of downstream genes. Complementing this direct approach, other inhibitors such as Sinomenine, HPI-4, CAY10494, and CCT007093 exert their inhibitory effects by interfering with FOXC1's transcriptional regulation or influencing its stability and expression.
Furthermore, indirect inhibition of FOXC1 is achieved through compounds like TGF-β Receptor Inhibitor III, JSH-23, SIS3, Pifithrin-α, LDN-193189, and SD-208. These compounds operate by targeting signaling pathways closely associated with FOXC1, including TGF-β, Smad3, p53, and BMP. By influencing these pathways, the inhibitors indirectly modulate FOXC1 activity, providing researchers with a versatile toolkit to explore the intricate regulatory networks involving FOXC1. Understanding the impact of these inhibitors on FOXC1-dependent cellular processes is instrumental in unraveling the complex mechanisms that govern gene expression and signaling pathways. Researchers can leverage these inhibitors to delve into the functional implications of FOXC1 modulation, shedding light on its contributions to normal cellular physiology and its potential role in aberrations observed in various pathological conditions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
HPI-4 | 302803-72-1 | sc-358720 sc-358720A | 5 mg 25 mg | $136.00 $541.00 | ||
HPI-4 is a chemical inhibitor specifically targeting FOXC1. It modulates FOXC1 activity, possibly by interacting with its transcriptional machinery. HPI-4-mediated inhibition results in the modulation of FOXC1-dependent gene expression, influencing cellular processes governed by FOXC1-mediated signaling pathways. | ||||||
NFκB Activation Inhibitor II, JSH-23 | 749886-87-1 | sc-222061 sc-222061C sc-222061A sc-222061B | 5 mg 10 mg 50 mg 100 mg | $214.00 $257.00 $1775.00 $2003.00 | 34 | |
This compound, also called JSH-23, is a chemical compound with inhibitory effects on FOXC1. It potentially modulates FOXC1 activity by interfering with its nuclear translocation or stability. JSH-23-mediated inhibition results in altered expression of FOXC1-dependent genes, influencing cellular processes governed by FOXC1-mediated signaling pathways. | ||||||
SIS3 hydrochloride | 521984-48-5 | sc-253565 | 5 mg | $334.00 | 2 | |
SIS3 is a selective inhibitor of the Smad3 pathway within the TGF-β signaling cascade, which is linked to FOXC1 regulation. By blocking Smad3 phosphorylation, SIS3 indirectly influences FOXC1 activity. The inhibition of Smad3 signaling leads to downstream effects on FOXC1-dependent gene expression, impacting cellular processes associated with FOXC1 functions. | ||||||
Pifithrin-α hydrobromide | 63208-82-2 | sc-45050 sc-45050A | 5 mg 25 mg | $120.00 $300.00 | 36 | |
Pifithrin-α(HBr) is a compound that inhibits p53 activity and may indirectly impact FOXC1. As FOXC1 is known to interact with p53, Pifithrin-α-mediated inhibition of p53 could influence FOXC1-dependent gene expression, impacting cellular processes associated with FOXC1. | ||||||
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
This compound, also called LDN-193189, is a selective inhibitor of BMP type I receptors, which are implicated in pathways interacting with FOXC1. By blocking BMP signaling, LDN-193189 indirectly modulates FOXC1 activity. The inhibition of BMP signaling leads to downstream effects on FOXC1-dependent gene expression, influencing cellular processes associated with FOXC1 functions. | ||||||
TGF-β RI Kinase Inhibitor V | 627536-09-8 | sc-203294 | 2 mg | $88.00 | 3 | |
TGF-β RI Kinase Inhibitor V (SD-208) is a selective TGF-βRI kinase inhibitor, impacting the TGF-β signaling pathway linked to FOXC1. By blocking TGF-β receptor activity, SD-208 indirectly modulates FOXC1 activity. The inhibition of TGF-β signaling leads to downstream effects on FOXC1-dependent gene expression, influencing cellular processes associated with FOXC1 functions. | ||||||